We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00874315
Recruitment Status : Withdrawn (lack of accrual)
First Posted : April 2, 2009
Last Update Posted : October 16, 2015
Information provided by (Responsible Party):
Nationwide Children's Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : June 2012
  Study Completion Date : June 2012